GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
==== Carotenosis ==== Carotenoderma, also referred to as carotenemia, is a benign and reversible medical condition where an excess of dietary carotenoids results in orange discoloration of the outermost skin layer. It is associated with a high blood β-carotene value. This can occur after a month or two of consumption of β-carotene rich foods, such as carrots, carrot juice, tangerine juice, mangos, or in Africa, red palm oil. β-carotene dietary supplements can have the same effect. The discoloration extends to palms and soles of feet, but not to the white of the eye, which helps distinguish the condition from jaundice. Consumption of greater than 30 mg/day for a prolonged period has been confirmed as leading to carotenemia.
Z-DNA binding protein 1, also known as Zuotin, is a Saccharomyces cerevisiae yeast gene. Zuo1 has been identified in vitro as a tRNA and Z-DNA binding protein. The name "zuotin" is derived from the Chinese word "zuo" meaning "left". It is a member of Hsp40 family. Like all other Hsp40 members it also contains a classic J domain. In 1990, Shuguang Zhang of MIT made a serendipitous discovery of a self-assembling peptide in yeast protein Zuotin. This discovery led to the development of a new field of peptide nanobiotechnology and to designs of a variety of self-assembling peptides for widespread uses, including peptide hydrogels in materials science, 3D tissue cell culture and tissue engineering, nanomedicine, sustained molecular releases, clinical and surgical applications. Zuotin and related proteins contain a unique Zuotin homology domain (ZHD). It associates with the Hsp70 family Ssz1 to form a ribosome associated complex (RAC). In such a complex, the N-terminal domains (including the J domain) associates with Ssz1p on the surface of the large (60S) ribosomal subunit. ZHD provides further contacts with the 60S subunit and connects to a subunit-spanning medium domain (MD), the "neck" of RAC. The four-helix-bundle RAC head domain is located at the C-terminus and binds the small (40S) subunit. The J domain-Ssz1p complex, located over the peptide exit tunnel of the large ribosomal subunit, helps the nascent peptide fold.
Portugal, officially the Portuguese Republic, is a country in Southwestern Europe. Mainland Portugal is located on the southwestern portion of the Iberian Peninsula, and bordered by Spain to the north and east. Portugal also includes the archipelagos of Madeira and the Azores in the Atlantic Ocean. The country has a population of 11.4 million, and Lisbon, its capital, is the largest city. Portugal's internal waters and territorial sea together account for two-fifths of its territory, and its exclusive economic zone is one of Europe's largest. The country's terrain contains a diverse range of landscapes and regional climates. The western Iberian Peninsula has been inhabited since prehistory, with the earliest signs of settlement dating to between 5500 BC and 5300 BC. Muslims had occupied the Iberian Peninsula since 711. As a result of the Reconquista against them, Portugal was established as a county of the Kingdom of León in 868 and formally as a kingdom in 1179. During the Age of Discovery, the kingdom made several advancements in nautical science and maritime exploration to discover new territories and sea routes, which led to the establishment of the Portuguese Empire. The kingdom became a republic in 1910, before becoming a dictatorship in 1926, whose 1974 overthrow enabled democracy to be established in 1976. Portugal is a unitary republic and multi-party representative democracy with four separate sovereignty organs: president, government, parliament, and judiciary.
According to the national tourist board, Speyside includes the area between the Highlands to the west and Aberdeenshire in the east, extending north from the Cairngorms National Park. According to one source, the top five in 2019 were Aberlour, Balvenie, Glenfarclas, Glenfiddich, and The Macallan. Region characteristics: vary greatly from "rich and textured to fragrantly floral"; in general, "sweet, "caramel", "fruity" and "spicy", according to the national tourist board. According to a marketing agency, the single malts from Speyside are known for a smokiness and complexity. It has the largest number of distilleries of any region, which includes: Aberlour, Balvenie, Cardhu, Cragganmore, Dalwhinnie, Glenfarclas, Glenglassaugh, Glenfiddich, Speyburn, The Glenlivet, The Glenrothes and The Macallan. Due to the way that the regions are specified, Speyside is wholly within the Highland region and thus whiskies produced in Speyside may legally be described as coming from either region; for example Glenfarclas generally labels their whiskies as Highland Single Malts. Although only five regions are specified, any Scottish locale may be used to describe a whisky if it is distilled entirely within that place; for example, a single malt whisky distilled in Orkney could be described as Orkney Single Malt Scotch Whisky instead of as an Island whisky.
Sources: en.wikipedia.org
In the West, the glass is normally a borosilicate glass (similar to Pyrex), while in the former Soviet Union it is normal to use a phosphate glass. The amount of fission products in the glass must be limited because some (palladium, the other Pt group metals, and tellurium) tend to form metallic phases which separate from the glass. Bulk vitrification uses electrodes to melt soil and wastes, which are then buried underground. In Germany, a vitrification plant is treating the waste from a small demonstration reprocessing plant which has since been closed.
== Structure == LRP5 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP6. In each protein, about 85% of its 1600-amino-acid length is extracellular. Each has four β-propeller motifs at the amino terminal end that alternate with four epidermal growth factor (EGF)-like repeats. Most extracellular ligands bind to LRP5 and LRP6 at the β-propellers. Each protein has a single-pass, 22-amino-acid segment that crosses the cell membrane and a 207-amino-acid segment that is internal to the cell.
There is extensive experience, over many years, of the use of radioiodine in the treatment of thyroid overactivity, and this experience does not indicate any increased risk of thyroid cancer following treatment. However, a study from 2007 has reported an increased number of cancer cases after radioiodine treatment for hyperthyroidism. The principal advantage of radioiodine treatment for hyperthyroidism is that it tends to have a much higher success rate than medications. Depending on the dose of radioiodine chosen, and the disease under treatment (Graves' vs. toxic goiter, vs. hot nodule, etc.), the success rate in achieving definitive resolution of the hyperthyroidism may vary from 75 to 100%. A major expected side-effect of radioiodine in people with Graves' disease is the development of lifelong hypothyroidism, requiring daily treatment with thyroid hormone. On occasion, some people may require more than one radioactive treatment, depending on the type of disease present, the size of the thyroid, and the initial dose administered. People with Graves' disease manifesting moderate or severe Graves' ophthalmopathy are cautioned against radioactive iodine-131 treatment, since it has been shown to exacerbate existing thyroid eye disease. People with mild or no ophthalmic symptoms can mitigate their risk with a concurrent six-week course of prednisone. The mechanisms proposed for this side effect involve a TSH receptor common to both thyrocytes and retro-orbital tissue.
The four substrates of this enzyme are (−)-(S)-limonene, reduced nicotinamide adenine dinucleotide phosphate (NADPH), oxygen, and a proton. Its products are (−)-perillyl alcohol, oxidised NADP+, and water. This enzyme is a cytochrome P450 protein containing heme. This oxidoreductase, which uses molecular oxygen as oxidant is in a group with systematic name (S)-limonene,NADPH:oxygen oxidoreductase (7-hydroxylating). Other names in common use include (−)-limonene 7-monooxygenase, (−)-limonene hydroxylase, (−)-limonene monooxygenase, and (−)-limonene,NADPH:oxygen oxidoreductase (7-hydroxylating). In Perilla frutescens it is part of the biosynthetic pathway to perillaldehyde.
==== Knight Grand Cross of the Royal Victorian Order (GCVO) ==== Captain Sir Alastair Sturgis Aird, , Private Secretary and Comptroller to Queen Elizabeth The Queen Mother. General Sir Geoffrey Richard Desmond Fitzpatrick, , Gold Stick.
Sources: en.wikipedia.org
== History == Both Adolf Jarisch, an Austrian dermatologist, and Karl Herxheimer, a German dermatologist, are credited with the discovery of the Jarisch–Herxheimer reaction. Both Jarisch and Herxheimer observed reactions in patients with syphilis treated with mercury. The reaction was first seen following treatment in early and later stages of syphilis treated with Salvarsan, mercury, or antibiotics. Jarisch thought that the reaction was caused by a toxin released from the dying spirochetes.
May 21, 1992: Decree concerning the responsibilities of the Secretary of State for Women's Rights and Consumer Affairs. July 22, 1992: Law reforming the provisions of the Penal Code relating to the repression of crimes and offenses against persons. November 2, 1992: Law concerning abuse of authority in sexual matters in work relationships and amending the Labour Code and the Code of Criminal Procedure. January 8, 1992: Law amending the Civil Code concerning civil status, family, and children's rights, and establishing the family affairs judge. January 27, 1993: Law concerning various social measures, notably establishing the offense of obstructing abortion and decriminalizing self-induced abortion. April 8, 1993: Decree concerning the responsibilities of the Minister of State, Minister of Social Affairs, Health, and the City. July 22, 1993: Law reforming nationality law. August 2, 1993: Law concerning the control of immigration and the conditions of entry, reception, and residence of foreigners in France. April 21, 1994: Discussion on the possibility of quotas and potential gender parity in the exercise of responsibilities, particularly political ones. July 15, 1994: Law concerning the family. July 29, 1994: Law concerning respect for the human body. July 29, 1994: Law concerning the donation and use of elements and products of the human body, medically assisted procreation, and prenatal diagnosis. June 1, 1995: Decree concerning the responsibilities of the Minister for Intergenerational Solidarity. October 18, 1995: Creation of the Observatory for Gender Parity.
In April 2023, Lula met with union leaders and took part in the Brazil-Spain Business Forum in Madrid. On 26 April, Lula, alongside several of his cabinet ministers, met with Spanish prime minister Pedro Sánchez at the Moncloa Palace, where he signed two different deals regarding education and work areas, which includes facilitating student exchange programmes between universities in both countries, expanding cooperation between in higher education and adopting regulations for IT companies Later on that day, Lula, Rosângela and FM Mauro Vieira met with King Felipe VI at the Royal Palace of Madrid. In March 2023, Lula received Sánchez in Brasília ahead of the 2024 G20 Rio de Janeiro summit to discuss trade relations between Brazil and Spain including the EU-Mercosur Association Agreement as well the reform of world institutions such as the United Nations and the World Bank.
== Medical uses == Mesocarb was originally developed in the Soviet Union in the 1970s for a variety of indications including asthenia, apathy, adynamia, and some clinical aspects of depression and schizophrenia. Mesocarb was used for counteracting the sedative effects of benzodiazepines, increasing workload capacity and cardiovascular function, treatment of attention deficit hyperactivity disorder (ADHD) in children, as a nootropic, and as a drug to enhance resistance to extremely cold temperatures. It has also been reported to have antidepressant and anticonvulsant properties.
All the proteolytic activity of the asparagine peptide lyases is only self-cleavages, then no further peptidase activity occurs. The main residue of the active site is the asparagine and there are other residues involved in the catalytic mechanism, which are different between the different families of asparagine peptide lyases. The cleavage mechanism consists in the cyclization of the asparagine, assisted by other active site residues. In certain conditions, the asparagine cyclic structure nucleophilically attacks its C-terminal peptide bond to the main chain forming a new bond to create a stable succinimide, cleaving itself from the main chain and consequently releasing the two halves of the product. No inhibitors are known.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。